Skin & aging Signal peptide
Palmitoyl tripeptide-38
Regulatory status
Status at a glance
503A compounding status
Not nominated
We found no pending nomination for the 503A bulks list. Unless the substance has another legal pathway (for example, a USP monograph or use in an FDA-approved drug), 503A pharmacies generally may not compound with it.
- FDA approval
- Not FDA-approved for any use
- 503B outsourcing
- Not determined
- Anti-doping (WADA)
- Not on the WADA Prohibited List
- DEA schedule
- Not a controlled substance
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Key takeaway
Palmitoyl tripeptide-38 is a fat-attached "signal" peptide, sold as Matrixyl synthe'6, designed to prompt skin cells to make several different matrix building blocks. Laboratory and manufacturer work report that it can stimulate collagen and other structural components, which is the basis for its use in products aimed at the appearance of smoother, firmer skin. As of 2026, the human evidence is limited to one open-label human study of a combined vitamin-and-peptide serum, so the ingredient's individual effect is not established.
At a glance
- What it is
- Cosmetic ingredient, a signal peptide (sold as Matrixyl synthe'6)
- FDA status
- Does not require FDA approval, as a cosmetic ingredient rather than a drug
- Research
- Activity rests on laboratory and manufacturer data; the one human study combined it with other actives
- Used in
- "Anti-aging" products for the look of wrinkles and firmness
- Evidence strength
- Low research
Summary
Palmitoyl tripeptide-38 is a cosmetic signal peptide sold as Matrixyl synthe'6. See how it works, what human evidence exists, and its regulatory status.
What is palmitoyl tripeptide-38?
Palmitoyl tripeptide-38 is a peptide of three amino acids joined to palmitic acid to aid skin penetration. It is a matrikine-style signal peptide designed to imitate sequences found in the skin's support proteins. It is made by Sederma and sold under the trade name Matrixyl synthe'6, used as its own active rather than as part of the Matrixyl 3000 pairing. It is a cosmetic ingredient, not a drug.
How does it work?
Laboratory studies describe palmitoyl tripeptide-38 as a signal that encourages skin cells to rebuild several matrix components at once. The marketing name "synthe'6" refers to the claim that it stimulates six constituents, the proteins and molecules that give skin and its layers structure and cushioning, including:
- Collagen types I, III, and IV
- Fibronectin
- Hyaluronic acid
- Laminin
The proposed result is a smoother, firmer-looking surface.
These are laboratory and manufacturer findings; the "six-component" claim comes from the ingredient maker's own studies. In finished cosmetics, the benefit is described in appearance terms, such as the look of softened wrinkles.
Is it FDA-approved?
Safety note
Status: Does not require FDA approval, as a cosmetic ingredient rather than a drug
Category: Cosmetic and topical · Primary body area: Skin & aging
No, and it does not need to be. The FDA does not pre-approve cosmetic ingredients. A cosmetic may describe effects on the appearance of skin, while a claim to rebuild the body's tissues would make a product a drug. Palmitoyl tripeptide-38 is used as a cosmetic ingredient, for the appearance of the skin.
What is it used for?
Palmitoyl tripeptide-38 is used in "anti-aging" serums and creams aimed at the look of forehead lines, crow's-feet, and overall wrinkle appearance, as well as smoother, firmer-looking skin.
What does the research show?
Editor’s note
Evidence strength: Low research
The only human study was open-label and combined the peptide with vitamins C and E, so there is no sound evidence isolating an appearance benefit from the ingredient itself.
The direct evidence is limited. According to PubMed, one open-label human study tested a serum combining palmitoyl tripeptide-38 with vitamins C and E and reported reduced skin roughness and improved tone over about two months. Because the serum also contained a high concentration of vitamin C, a potent active in its own right, and because the study had no control group, the peptide's individual contribution cannot be isolated. The remaining efficacy data are manufacturer studies. No independent, controlled single-ingredient trial was found.
What are the side effects?
Palmitoyl tripeptide-38 is generally reported as well tolerated on the skin, and the combined-serum study above reported no notable adverse reactions. As with any new product, a patch test is sensible for sensitive or reactive skin.
Sources: an open-label study of a vitamin-and-peptide serum (Lintner et al., Journal of Cosmetic Dermatology, 2020, DOI: 10.1111/jocd.13770), indexed on PubMed; and manufacturer and cosmetic ingredient reference data on Matrixyl synthe'6. This document is educational and does not constitute medical advice.
Registered human trials
0 registered human trials on ClinicalTrials.gov that we reviewed
Sources
- [1]
Compare every peptide’s status in the peptide regulatory status database
More for Skin & aging
View all skin & aging peptides →- Cosmetic & topical Skin & aging
Acetyl-Hexapeptide-8
Argireline
Acetyl hexapeptide-8, sold in skincare as Argireline, is a synthetic peptide modeled on the nerve protein SNAP-25 and marketed as a topical, "Botox-like" way to soften the appearance of expression lines. In lab and small clinical studies it interferes with the SNARE complex that nerves use to trigger muscle contraction, and a 2013 randomized study found it reduced the appearance of peri-orbital wrinkles over four weeks. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Moderate.
- Cosmetic & topical Skin & aging
Acetyl-Octapeptide-3
SNAP-8
Acetyl octapeptide-3, sold in skincare as SNAP-8, is a synthetic eight-amino acid peptide modeled on the nerve protein SNAP-25 and marketed as a stronger successor to Argireline for softening the appearance of expression lines. Like Argireline, it is designed to interfere with the SNARE complex that nerves use to trigger muscle contraction, but its own published human evidence is thin and comes mostly from the manufacturer. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Low.
- Cosmetic & topical Skin & aging
Acetyl-Tetrapeptide-5
Eyeseryl
Acetyl tetrapeptide-5, sold in skincare as Eyeseryl, is a synthetic four-amino acid peptide used in eye creams to soften the look of under-eye bags and puffiness. It is thought to work in two ways, by easing the fluid buildup that makes the under-eye area look swollen and by limiting the glycation that stiffens collagen, though its published evidence comes almost entirely from the manufacturer. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Low.
- FDA-approved Skin & aging
Afamelanotide
Afamelanotide is a synthetic, longer-lasting analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates the MC1R receptor on pigment cells to boost the skin's own protective eumelanin. The FDA approved it in 2019 as Scenesse, a subcutaneous implant for adults with erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder. In the pivotal 2015 placebo-controlled trials, U.S. patients (94) logged a median 69.4 pain-free hours in direct sunlight versus 40.8 on placebo (P = 0.04). EU patients (74) logged 6.0 versus 0.8 hours (P = 0.005).
- FDA-approved Skin & aging
Bacitracin
Bacitracin is a cyclic polypeptide antibiotic produced by Bacillus bacteria that kills gram-positive bacteria by blocking the construction of their cell wall. It is best known as an over-the-counter topical ointment for preventing infection in minor cuts, scrapes, and burns, often combined with neomycin and polymyxin B in "triple antibiotic" products. It is widely available over the counter, but it is also a common cause of allergic skin reactions, and its injectable form was withdrawn over kidney-toxicity concerns.
- Cosmetic & topical Skin & aging
Carnosine
Carnosine is a naturally occurring dipeptide, made of the amino acids beta-alanine and histidine, used in skincare as an antioxidant ingredient. Laboratory and ex-vivo skin studies suggest it can neutralize reactive oxygen species and limit glycation, a process in which sugars stiffen skin proteins, which is the rationale for using it in products aimed at the appearance of aging skin. As of 2026, the evidence for topical carnosine is largely from lab and ex-vivo studies rather than large human appearance trials.